Li Qinyi, Zhao Xiaohong, Yang Huan, Zhu Xiaolong, Sui Xinbing, Feng Jiao
School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China.
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1599. doi: 10.3390/ph17121599.
Endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) play critical roles in tumorigenesis, cancer progression, and drug resistance. Persistent activation of the ER stress system enhances the survival capacities of malignant tumor cells, including increased proliferation, invasion, and resistance to treatment. Dysregulation of ER function and the resultant stress is a common cellular response to cancer therapies and may lead to cancer cell death. Currently, growing evidence suggests that Traditional Chinese medicine (TCM), either as a monotherapy or in combination with other treatments, offers significant advantages in preventing cancer, inhibiting tumor growth, reducing surgical complications, improving drug sensitivity, and mitigating drug-induced damage. Some of these natural products have even entered clinical trials as primary or complementary anticancer agents. In this review, we summarize the anticancer effects of TCM monomers/natural products on the gastrointestinal (GI) tumors and explore their mechanisms through ER stress modulation. We believe that ongoing laboratory research and the clinical development of TCM-based cancer therapies hold considerable potential for advancing future cancer treatments.
内质网(ER)应激和未折叠蛋白反应(UPR)在肿瘤发生、癌症进展和耐药性中起着关键作用。ER应激系统的持续激活增强了恶性肿瘤细胞的生存能力,包括增加增殖、侵袭和对治疗的抗性。ER功能失调及由此产生的应激是癌症治疗常见的细胞反应,可能导致癌细胞死亡。目前,越来越多的证据表明,中药无论是作为单一疗法还是与其他治疗方法联合使用,在预防癌症、抑制肿瘤生长、减少手术并发症、提高药物敏感性以及减轻药物诱导的损伤方面都具有显著优势。其中一些天然产物甚至已作为主要或辅助抗癌药物进入临床试验。在本综述中,我们总结了中药单体/天然产物对胃肠道(GI)肿瘤的抗癌作用,并通过ER应激调节探索其作用机制。我们相信,正在进行的实验室研究以及基于中药的癌症治疗的临床开发在推进未来癌症治疗方面具有巨大潜力。